Bio-Techne Corp at Wells Fargo Healthcare Conference Transcript

Sep 07, 2022 / 01:10PM GMT
Timothy Ian Daley - Wells Fargo Securities, LLC, Research Division - Associate Analyst

All right. Great. So I am Tim Daley, Senior Analyst for the Life Science Tools, Diagnostics and Pharma Services sector here at Wells Fargo. I want to thank everybody for attending the 2022 Wells Fargo Healthcare Conference here in Boston. Honored today to have representatives from Bio-Techne. Joining me on the stage, we've got Jim Hippel, CFO; and then Will Geist, the President of the Protein Sciences division.

So we're going to go through some questions and answers. And then the last kind of 10 minutes or so, we will open it up for Q&A if anybody wants to join in. So great. Thanks for having.

James T. Hippel - Bio-Techne Corporation - Executive VP of Finance & CFO

Thanks for having us, Tim.

Questions and Answers:

Timothy Ian Daley - Wells Fargo Securities, LLC, Research Division - Associate Analyst

Appreciate it. So yes, so given there's been a lot of movement in the macro environment over the last few weeks
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot